SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Herpes Simplex Virus Encephalitis

Enter Course



Course Description

This program is worth up to 2.0 CME credits.

Early recognition and treatment of herpes simplex virus (HSV) encephalitis can reduce mortality from 70% to 25%. This course will enhance early recognition of the typical and atypical symptoms and signs of HSV encephalitis, improve understanding of the diagnostic approach to confirming HSV encephalitis, and provide justification for early initiation of empiric acyclovir for presumptive HSV encephalitis.

Up to 2.0 CME credits

Pricing

Members: FREE $39.00*
Nonmembers: $69.00

*Free access is limited to one course at a time for eligible members.

Learning Objectives

As a result of this program the learner will:

Identify typical and atypical symptoms and signs of HSV encephalitis, distinguish the appropriate diagnostic approach for confirming HSV encephalitis and recognize the importance of early initiation of empiric acyclovir when HSV encephalitis is suspected.

Core Competencies

  • Patient Care
  • Medical Knowledge
  • Practice-Based Learning and Improvement

Date of Release

November 29, 2016

This module is eligible for CME credits for three years from the release date.

Confidentiality of Data

All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved.

See complete Terms of Use.

Faculty & Disclosures

JOSEPH R. ZUNT, MD, MPH
Professor, Departments of Neurology and Global Health
Adjunct Professor, Departments of Medicine - Infectious Diseases and Epidemiology
University of Washington
*Dr. Zunt has nothing to disclose.

Editor, NeuroLearn

A. GORDON SMITH, MD, FAAN
University of Utah Department of Neurology
Salt Lake City, Utah
*Dr. Smith has received personal compensation from CSL Behring, Grifols, and Allergan, as a consultant. Dr. Smith has received research support from NIH, the ADA, and Impeto. Dr. Smith has received compensation in an editorial capacity for NeuroLearn.

Item Reviewer

CHARLES ZOLLINGER, MD, FAAN
Medical Director, Stroke & Neurosciences
Associate Clinical Professor
NeuroCare Center Inc., Aultman Hospital, Canton, Ohio
Northeast Ohio Medical University, Rootstown, Ohio
*Dr. Zollinger has nothing to disclose.

NeuroLearn Staff:

Minneapolis, Minnesota

Maureen Holtzman, Senior Manager, Education
*Ms. Holtzman has nothing to disclose.

Angela Elliott, Program Manager, eLearning
*Ms. Elliott has nothing to disclose.

Robert Rook, Program Manager, Digital Education Resources
*Mr. Rook has nothing to disclose.

Susan Rodmyre, Senior Director, Education
*Ms. Rodmyre has nothing to disclose.

Andrew Leaf, Web Developer
*Mr. Leaf has nothing to disclose.

Kurt Wiersma, Senior Manager, Web Development
*Mr. Wiersma has nothing to disclose.

*Relationship Disclosure

Enter Course

MEMBER LOG IN

Forgot Password?